Samvardhana Motherson International Ltd
MOTHERSONSamvardhana Motherson International Ltd's price has outrun its earnings. +84.3% in a year against EPS +1.7% — the market is paying now for delivery later.
The sharpest disagreement: the price moved +84.3% in a year while annual EPS moved +1.7% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (44 weeks in) while the P/E sits at the 70th percentile of its own 11-year range. Underneath, the last four quarters read improving — profit +77.6% year on year, and 223% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Samvardhana Motherson International Ltd trades at ₹169, in a confirmed uptrend and 44 weeks into that stage. That is +31.4% against its own 200-day average. It sits at 100% of a 52-week range of ₹104 to ₹169. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 2 straight weeks.
Today the stock is in a confirmed uptrend — week 44 of stage 2, confirmed. At ₹169 it trades +31.4% versus its 200-day average and sits at 100% of its 52-week range (₹104–₹169).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +372% while the NIFTY 500 moved +286% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 2 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Samvardhana Motherson International Ltd trades at 38.9× P/E, at the pricey end of its own range (70th percentile). Its long-run median P/E is 32.8×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 38.9× is at the pricey end of its own range (70th percentile), against a long-run median of 32.8× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved +1.7% against a +84.3% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 5y, of the +14.4%/yr price move, ~+23.5%/yr came from earnings growth and ~−9.1 pp from the multiple (compressing); over 10y, of the +11.5%/yr price move, ~+8.4%/yr came from earnings growth and ~+3.1 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Samvardhana Motherson International Ltd reads as turning around on its fundamental arc. Turning around — profit growth swung from −13.9% at the trough to +24.7%, a 2-quarter improving streak, ROCE lifting at 14.2%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +10.9% | +17.0% | +17.1% | +13.0% |
| Profit | −1.4% | +34.7% | +21.1% | +8.7% |
| EPS | +1.7% | +35.5% | +20.2% | +6.6% |
| Share price | +84.3% | +37.7% | +14.4% | +11.5% |
4-Factor Sector Score
51.0/100 — rank 11 of 20 in Auto Ancillaries - Diversified · 100% evidence confidence
Samvardhana Motherson International Ltd scores 51.0 out of 100 against the 20 companies it is compared with in Auto Ancillaries - Diversified, ranking 11. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 20.4 + 8.4 + 5.1 + 17.1 = 51. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Samvardhana Motherson International Ltd reported ₹35,244 Cr of revenue in the Jun 26 quarter, +16.7% year on year. That is the 12th straight quarter of year-on-year growth. Over 10 years it has compounded at 13.0% a year. The last full year, FY26, came in at ₹1,26,104 Cr. The last four reported quarters add to ₹1,31,135 Cr.
FY26 revenue came in at ₹1,26,104 Cr (+10.9% on the year), capping 10 years at 13.0% compound. The latest quarter (Jun 26) printed ₹35,244 Cr, +16.7% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +13.9% growth against the decade's 13.0% — the current year is running in line with its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +14.0% over the last 4 quarters against +11.7%/yr over the last 8 — stabilising; TTM profit +24.7% vs +14.6%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Samvardhana Motherson International Ltd's operating margin is 9.0% in the Jun 26 quarter, +1.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 13 fiscal years the operating margin has ranged 7.0% to 10.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 9.0%, +1.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 7.0%–10.0%, and FY26's 10.0% is the top of that band — a record year.
Why the margin moved: operating margin went +0.6 pp year on year while gross margin went −0.9 pp — the gain came mostly from the gross line: input costs and pricing.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Samvardhana Motherson International Ltd earned ₹1,076 Cr of net profit in the Jun 26 quarter, +77.6% year on year. It is the 3rd consecutive quarter of growth. Full-year FY26 profit was ₹4,086 Cr. The 10-year compound rate is 8.7%. That is 3.1% of the quarter's revenue. The same quarter a year earlier earned ₹606 Cr.
Jun 26 profit was ₹1,076 Cr, +77.6% year on year — the 3rd consecutive quarter of growth. On the full year, FY26 printed ₹4,086 Cr (−1.4%), and the 10-year compound rate is 8.7%.
Why profit moved: revenue contributed +16.7% and the margin +1.0 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +28.9% vs revenue +13.9%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 223% of Samvardhana Motherson International Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹11,284 Cr of operating cash against ₹4,086 Cr of profit. After ₹11,899 Cr of capital spending, ₹−615 Cr was left as free cash.
FY26: operating cash of ₹11,284 Cr against reported profit of ₹4,086 Cr, leaving free cash of ₹−615 Cr after ₹11,899 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 223% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 223%: the cash cycle held roughly steady between FY21 and FY26 — so conversion tracks profitability rather than the cycle.
Router verdict: the bigger cash user is investment — capital spending ran 2.3× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Samvardhana Motherson International Ltd's cash conversion cycle runs −26 days in FY26, up from −29 days in FY21. Capital spending ran ₹31,404 Cr over the last 3 years. At FY26 sales of ₹1,26,104 Cr each day of that cycle holds about ₹345 Cr, so roughly ₹−8,983 Cr sits inside the business at any moment.
FY26: debtors at 58 days, inventory at 68 days — roughly 2.2 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of −26 days, looser than FY21's −29.
The full loop: cash goes out to suppliers and production on day 0; stock waits 68 days to sell; customers pay about 58 days after that; and suppliers themselves are paid at 152 days — netting out to the −26-day cycle.
In money terms: at FY26 sales of ₹1,26,104 Cr, each day of the cycle holds about ₹345 Cr — so the −26-day loop keeps roughly ₹−8,983 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹31,404 Cr over the last 3 fiscal years against ₹13,437 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹4,094 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Samvardhana Motherson International Ltd earns a ROCE of 13% in FY26. That is up from a trough of 6% in FY21. Return on invested capital clears the cost of that capital by −2.2 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 3.2% net margin on 1.15× asset turns.
FY26 ROCE is 13%, recovered from a FY21 trough of 6% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 3.2% net margin × 1.15× asset turns × 2.67× balance-sheet leverage ≈ 9.8% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 9.8% − 12.0% = a −2.2 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Samvardhana Motherson International Ltd carries total debt of ₹19,170 Cr against shareholder equity of ₹43,659 Cr as of Jun 26, a debt-to-equity of 0.44. On the annual view that ratio went from 0.63 in FY22 to 0.44 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Jun 26: total debt of ₹19,170 Cr against shareholder equity of ₹43,659 Cr — a debt-to-equity of 0.44. On the annual view, debt-to-equity went from 0.63 (FY22) to 0.44 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters cut 11.8 points of Samvardhana Motherson International Ltd over 8 quarters, the biggest move on the register. That takes promoters to 48.6% of the company. Domestic institutions moved +2.6 points over the same window, to 20.6%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −11.8 points over 8 quarters to 48.6%; Domestic institutions: +2.6 points over 8 quarters to 20.6%; Foreign institutions: +0.0 points over 8 quarters to 12.9%.
🚨 Why the register moved: promoters drove it (−11.8 points), absorbed on the other side by domestic institutions (+2.6 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Samvardhana Motherson International Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1S J S Enterprises LtdSJS | 74.2/100Favorable setup97% evidence | LEADER | 30.0/35 Revenue 28.6% · PAT 67.5% · OPM change 2 pp 95% evidence | 19.4/25 ROCE 28.6% · OPM 29% 95% evidence | 10.6/20 P/E 41.1× · PEG 0.89 100% evidence | 14.2/20 RS sector 17.8% · RS bench 35.4% · 1Y 111.5%12 of 12 weeks ahead 100% evidence |
| Exact sum: 30 + 19.4 + 10.6 + 14.2 = 74.2 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Jay Bharat Maruti LtdJAYBARMARU | 67.1/100Favorable setup87% evidence | BREAKING OUT | 23.3/35 Revenue 11.4% · PAT 100% · OPM change -2 pp 95% evidence | 12.3/25 ROCE 16.6% · OPM 10% 95% evidence | 14.4/20 P/E 10.9× · PEG — 50% evidence | 17.1/20 RS sector 12.1% · RS bench 28.1% · 1Y 65.2%11 of 12 weeks ahead 100% evidence |
| Exact sum: 23.3 + 12.3 + 14.4 + 17.1 = 67.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Lumax Auto Technologies LtdLUMAXTECH | 64.9/100Mixed-positive evidence96% evidence | ASLEEP | 26.6/35 Revenue 33.9% · PAT 47% · OPM change 0 pp 88% evidence | 17.2/25 ROCE 21.2% · OPM 14% 100% evidence | 11.9/20 P/E 41.4× · PEG 0.75 100% evidence | 9.2/20 RS sector -1.4% · RS bench 13.9% · 1Y 58.2%1 of 12 weeks ahead 100% evidence |
| Exact sum: 26.6 + 17.2 + 11.9 + 9.2 = 64.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Sansera Engineering LtdSANSERA | 63.9/100Mixed-positive evidence96% evidence | LEADER | 26.3/35 Revenue 15.9% · PAT 50.2% · OPM change 3 pp 88% evidence | 14.7/25 ROCE 14.1% · OPM 19% 100% evidence | 3.8/20 P/E 71.7× · PEG 2.22 100% evidence | 19.1/20 RS sector 54.7% · RS bench 76.4% · 1Y 190.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 26.3 + 14.7 + 3.8 + 19.1 = 63.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5OBSC Perfection LtdOBSCP | 58.7/100Mixed-positive evidence72% evidence | LEADER | 14.8/35 Revenue 0.1% · PAT 15.7% · OPM change 1.3 pp 71% evidence | 15.2/25 ROCE 19.5% · OPM 17.1% 95% evidence | 8.7/20 P/E 71.7× · PEG — 15% evidence | 20.0/20 RS sector 70% · RS bench 93.7% · 1Y 153.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 14.8 + 15.2 + 8.7 + 20 = 58.7 · Decision use: Price leads the evidence: RS versus the benchmark is 93.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 6Carraro India LtdCARRARO | 58.4/100Mixed-positive evidence93% evidence | FADING | 24.7/35 Revenue 24.8% · PAT 47.2% · OPM change -2 pp 100% evidence | 15.5/25 ROCE 29.5% · OPM 8% 100% evidence | 16.0/20 P/E 20.4× · PEG 0.41 65% evidence | 2.2/20 RS sector -17.9% · RS bench -5% · 1Y 3.8%6 of 12 weeks ahead 100% evidence |
| Exact sum: 24.7 + 15.5 + 16 + 2.2 = 58.4 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -17.9% and the one-year return is 3.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 7Minda Corporation LtdMINDACORP | 57.7/100Mixed-positive evidence90% evidence | BREAKING OUT | 23.7/35 Revenue 22.3% · PAT 40.4% · OPM change 0 pp 88% evidence | 11.7/25 ROCE 12.7% · OPM 12% 100% evidence | 8.9/20 P/E 48.5× · PEG 1.58 100% evidence | 13.4/20 RS sector 1.8% · RS bench 21.8% · 1Y 47.2%10 of 11 weeks ahead 70% evidence |
| Exact sum: 23.7 + 11.7 + 8.9 + 13.4 = 57.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Automobile Corporation Of Goa LtdAUTOCORP | 57.7/100Mixed-positive evidence82% evidence | ASLEEP | 25.8/35 Revenue 41.1% · PAT 48.9% · OPM change -6 pp 95% evidence | 16.7/25 ROCE 29.6% · OPM 5% 76% evidence | 12.8/20 P/E 18.4× · PEG — 50% evidence | 2.4/20 RS sector -19.4% · RS bench -7% · 1Y -16.8%11 of 12 weeks ahead 100% evidence |
| Exact sum: 25.8 + 16.7 + 12.8 + 2.4 = 57.7 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -19.4% and the one-year return is -16.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 9Bosch LtdBOSCHLTD | 53.2/100Mixed-positive evidence78% evidence | LEADER | 20.1/35 Revenue 10.8% · PAT 37.5% · OPM change 1 pp 83% evidence | 17.5/25 ROCE 21.5% · OPM 14% 76% evidence | 6.5/20 P/E 60.7× · PEG — 50% evidence | 9.1/20 RS sector -3.4% · RS bench 11.8% · 1Y 6.3%10 of 12 weeks ahead 100% evidence |
| Exact sum: 20.1 + 17.5 + 6.5 + 9.1 = 53.2 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 10Suprajit Engineering LtdSUPRAJIT | 52.3/100Mixed-positive evidence94% evidence | BREAKING OUT | 25.9/35 Revenue 18.4% · PAT 73.2% · OPM change 3 pp 100% evidence | 9.4/25 ROCE 16% · OPM 12% 100% evidence | 6.0/20 P/E 38.1× · PEG 5.51 100% evidence | 11.0/20 RS sector -2.4% · RS bench 12.5% · 1Y 14.8%9 of 11 weeks ahead 70% evidence |
| Exact sum: 25.9 + 9.4 + 6 + 11 = 52.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Samvardhana Motherson International Ltdthis pageMOTHERSON | 51.0/100Mixed-positive evidence100% evidence | LEADER | 20.4/35 Revenue 14% · PAT 24.7% · OPM change 1 pp 100% evidence | 8.4/25 ROCE 13.4% · OPM 9% 100% evidence | 5.1/20 P/E 38.9× · PEG 5.68 100% evidence | 17.1/20 RS sector 17.5% · RS bench 35.2% · 1Y 76.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 20.4 + 8.4 + 5.1 + 17.1 = 51 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Varroc Engineering LtdVARROC | 50.7/100Mixed-positive evidence87% evidence | BREAKING OUT | 17.0/35 Revenue 14.7% · PAT 39.9% · OPM change -2 pp 100% evidence | 9.3/25 ROCE 19% · OPM 8% 100% evidence | 14.6/20 P/E 43.4× · PEG 0.63 65% evidence | 9.8/20 RS sector -8.4% · RS bench 34.2% · 1Y 55%10 of 11 weeks ahead 70% evidence |
| Exact sum: 17 + 9.3 + 14.6 + 9.8 = 50.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Endurance Technologies LtdENDURANCE | 49.4/100Mixed-negative evidence96% evidence | BREAKING OUT | 17.7/35 Revenue 26.3% · PAT 13.8% · OPM change 0 pp 88% evidence | 15.4/25 ROCE 17.8% · OPM 14% 100% evidence | 7.4/20 P/E 43.8× · PEG 2.74 100% evidence | 8.9/20 RS sector -6.9% · RS bench 7.9% · 1Y 17.3%9 of 12 weeks ahead 100% evidence |
| Exact sum: 17.7 + 15.4 + 7.4 + 8.9 = 49.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Sharda Motor Industries LtdSHARDAMOTR | 48.9/100Mixed-negative evidence90% evidence | ASLEEP | 12.9/35 Revenue 19.8% · PAT 9.5% · OPM change -1 pp 88% evidence | 17.5/25 ROCE 36% · OPM 12% 100% evidence | 11.8/20 P/E 16.3× · PEG 2.02 100% evidence | 6.7/20 RS sector -16.8% · RS bench -0.2% · 1Y -10.4%0 of 10 weeks ahead 70% evidence |
| Exact sum: 12.9 + 17.5 + 11.8 + 6.7 = 48.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15NDR Auto Components LtdNDRAUTO | 48.8/100Mixed-negative evidence77% evidence | ASLEEP | 18.4/35 Revenue 15.4% · PAT 17% · OPM change 1 pp 83% evidence | 15.7/25 ROCE 22.2% · OPM 12% 95% evidence | 9.7/20 P/E 31.5× · PEG — 50% evidence | 5.0/20 RS sector -22.4% · RS bench -3.7% · 1Y -15.1%8 of 10 weeks ahead 70% evidence |
| Exact sum: 18.4 + 15.7 + 9.7 + 5 = 48.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Motherson Sumi Wiring India LtdMSUMI | 40.5/100Mixed-negative evidence94% evidence | ASLEEP | 10.0/35 Revenue 23.1% · PAT 3% · OPM change -2 pp 100% evidence | 16.8/25 ROCE 38.9% · OPM 8% 100% evidence | 7.1/20 P/E 43.5× · PEG 6.28 100% evidence | 6.6/20 RS sector -6.9% · RS bench -6.2% · 1Y 9.7%0 of 10 weeks ahead 70% evidence |
| Exact sum: 10 + 16.8 + 7.1 + 6.6 = 40.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17ZF Commercial Vehicle Control System India LtdZFCVINDIA | 40.1/100Mixed-negative evidence100% evidence | TURNING | 10.6/35 Revenue 9% · PAT 3.1% · OPM change 0 pp 100% evidence | 13.9/25 ROCE 19.4% · OPM 13% 100% evidence | 8.5/20 P/E 59.4× · PEG 4.2 100% evidence | 7.1/20 RS sector -80.2% · RS bench 8.1% · 1Y -79.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 10.6 + 13.9 + 8.5 + 7.1 = 40.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Munjal Auto Industries LtdMUNJALAU | 34.9/100Adverse evidence77% evidence | TURNING | 10.7/35 Revenue 11.1% · PAT 18.2% · OPM change -3.7 pp 83% evidence | 6.2/25 ROCE 11.1% · OPM 3% 95% evidence | 9.0/20 P/E 29× · PEG — 50% evidence | 9.0/20 RS sector -8.8% · RS bench 15.3% · 1Y 38.1%10 of 10 weeks ahead 70% evidence |
| Exact sum: 10.7 + 6.2 + 9 + 9 = 34.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Precision Camshafts LtdPRECAM | 31.8/100Adverse evidence77% evidence | ASLEEP | 9.9/35 Revenue -10.6% · PAT -5.6% · OPM change 0 pp 83% evidence | 8.7/25 ROCE 7.3% · OPM 13% 95% evidence | 9.6/20 P/E 55.2× · PEG — 50% evidence | 3.6/20 RS sector -32% · RS bench -12.6% · 1Y -18.6%6 of 10 weeks ahead 70% evidence |
| Exact sum: 9.9 + 8.7 + 9.6 + 3.6 = 31.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Mercury EV-Tech LtdMERCURYEV | 23.4/100Adverse evidence70% evidence | TURNING | 7.9/35 Revenue 13.9% · PAT -47.2% · OPM change -8.7 pp 83% evidence | 3.5/25 ROCE 2.6% · OPM -11.6% 95% evidence | 8.5/20 P/E 159× · PEG — 15% evidence | 3.5/20 RS sector -39% · RS bench -8.8% · 1Y -31%3 of 7 weeks ahead 70% evidence |
| Exact sum: 7.9 + 3.5 + 8.5 + 3.5 = 23.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Samvardhana Motherson International Ltd's share price today?
Samvardhana Motherson International Ltd trades at ₹169, +84.3% over the past year. The company is valued at ₹1,77,842 Cr. The stock sits at the very top of its 52-week range (₹104–₹169), +31.4% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 44 weeks in. — as of 7 August 2026.
What were Samvardhana Motherson International Ltd's latest quarterly results?
Samvardhana Motherson International Ltd reported revenue of ₹35,244 Cr and net profit of ₹1,076 Cr for the Jun 26 quarter. Revenue rose 16.7% and profit rose 77.6% year on year. Earnings per share were ₹0.98. The operating margin was 9.0%, 1.0 pp higher than a year earlier. — as of 7 August 2026.
What is Samvardhana Motherson International Ltd's revenue?
Samvardhana Motherson International Ltd reported revenue of ₹35,244 Cr in the Jun 26 quarter, +16.7% year on year. For the full FY26 fiscal year, revenue was ₹1,26,104 Cr (+10.9%). Over the last 10 years revenue compounded at 13.0% a year. — as of 7 August 2026.
What is Samvardhana Motherson International Ltd's profit?
Samvardhana Motherson International Ltd earned ₹1,076 Cr of net profit in the Jun 26 quarter, +77.6% year on year — the 3rd straight quarter of growth. Full-year FY26 profit was ₹4,086 Cr. The operating margin ran 9.0% in the latest quarter. — as of 7 August 2026.
What is Samvardhana Motherson International Ltd's market cap?
Samvardhana Motherson International Ltd's market capitalisation is ₹1,77,842 Cr at a share price of ₹169. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 7 August 2026.
What is Samvardhana Motherson International Ltd's P/E ratio?
Samvardhana Motherson International Ltd trades at a P/E of 38.9×, at the 70th percentile of its own 11-year range, against a long-run median of 32.8×. This is a comparison with the stock's own history, not a value call — as of 7 August 2026.
Does Samvardhana Motherson International Ltd pay a dividend?
Yes — Samvardhana Motherson International Ltd's dividend payout was 16% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 7 August 2026.
Is Samvardhana Motherson International Ltd overvalued?
On its own history, Samvardhana Motherson International Ltd looks expensive: its P/E of 38.9× sits at the 70th percentile of its 11-year range (long-run median 32.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 7 August 2026.
Is Samvardhana Motherson International Ltd growing?
Yes — Samvardhana Motherson International Ltd is growing: latest-quarter revenue +16.7% year on year, profit +77.6%, and the margin +1.0 pp at 9.0%. The 10-year compound rates are 13.0% (revenue) and 8.7% (profit). The earnings engine currently reads: improving — as of 7 August 2026.
How is Samvardhana Motherson International Ltd performing?
Samvardhana Motherson International Ltd is in a confirmed uptrend, 44 weeks in. Its latest quarter's revenue rose 16.7% and profit rose 77.6% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 2 weeks. This describes what the data did, not a rating. — as of 7 August 2026.
What stage is Samvardhana Motherson International Ltd in?
Turning around — profit growth swung from −13.9% at the trough to +24.7%, a 2-quarter improving streak, ROCE lifting at 14.2%. The read comes from the last 12 quarters of growth (revenue growth +14.0% latest, profit growth +24.7% latest, eps growth +32.2% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 7 August 2026.
Is Samvardhana Motherson International Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 44 of stage 2), trading +31.4% versus its 200-day average and at the very top of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 7 August 2026.
Is Samvardhana Motherson International Ltd beating the market?
On recent form, yes — Samvardhana Motherson International Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 2 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +372% against the NIFTY 500's +286% — ahead of the index over the full window. — as of 7 August 2026.
Will Samvardhana Motherson International Ltd's share price go up?
This page publishes no price forecast for Samvardhana Motherson International Ltd. What it measures instead: the share price is ₹169, the price is in a confirmed uptrend 44 weeks in. Its P/E of 38.9× sits at the 70th percentile of its own 11-year range. — as of 7 August 2026.
Who owns Samvardhana Motherson International Ltd?
Promoters hold 48.6% of Samvardhana Motherson International Ltd, foreign institutions 12.9%, domestic institutions 20.6% and the public 17.7% (latest quarter). The biggest move on the register over the last two years: Promoters cut 11.8 points over 8 quarters. — as of 7 August 2026.
Does Samvardhana Motherson International Ltd have too much debt?
It is moderate — Samvardhana Motherson International Ltd's debt-to-equity is 0.47, and operating profit covers the interest bill 8×. FY26 borrowings were ₹19,170 Cr against equity of ₹40,979 Cr. Read the returns on this page with that leverage in mind — as of 7 August 2026.
What is Samvardhana Motherson International Ltd's capex?
Samvardhana Motherson International Ltd spent ₹31,404 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹11,899 Cr, with ₹4,094 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 7 August 2026.
What is Samvardhana Motherson International Ltd's cash flow?
Samvardhana Motherson International Ltd generated ₹11,284 Cr of operating cash flow in FY26 and ₹−615 Cr of free cash flow after ₹11,899 Cr of capital spending. Reported profit that year was ₹4,086 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 7 August 2026.
Is Samvardhana Motherson International Ltd's profit real cash?
Yes — over the last 3 fiscal years, 223% of Samvardhana Motherson International Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹11,284 Cr against reported profit of ₹4,086 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 7 August 2026.
Where is Samvardhana Motherson International Ltd in its business cycle?
Samvardhana Motherson International Ltd's FY26 operating margin was 10.0%, against a 13-year band of 7.0%–10.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 9.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 7 August 2026.
What could break the Samvardhana Motherson International Ltd story?
The sharpest disagreement: the price moved +84.3% in a year while annual EPS moved +1.7% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 7 August 2026.
Is Samvardhana Motherson International Ltd a stock worth studying right now?
This is not investment advice. The machine read: Samvardhana Motherson International Ltd's price has outrun its earnings. +84.3% in a year against EPS +1.7% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 7 August 2026.